• News
  • Anal Cancer
  • Bladder Cancer
  • Bone Cancer
  • Brain Cancer
  • Breast Cancer
  • Cancer of Unknown Primary
  • Cervical Cancer
  • Colon Cancer
  • Esophageal Cancer
  • Gastric Cancer
  • GIST
  • Head & Neck Cancer
  • Hodgkins Lymphoma
  • Leukemia
    • Acute Leukemia
    • Chronic Lymphocytic Leukemia
    • Chronic Myeloid Leukemia
  • Liver Cancer
  • Lung Cancer
  • Melanoma
  • Mesothelioma
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • MPN-PV-ET-MF
  • Neuroblastoma
  • Neuroendocrine Tumors
  • Non Hodgkins Lymphoma
  • Ovarian Cancer
  • Pancreatic Cancer
  • Prostate Cancer
  • Renal Cancer
  • Rectal Cancer
  • Sarcoma
  • Skin Care
  • Skin Cancer
  • Testicular Cancer
  • Thyroid Cancer
  • Triple Negative Breast Cancer
  • Uterine Cancer
  • About Us
  • Advertising
  • News
  • Newly Diagnosed
  • Treatment & Care
  • Survivorship
  • Join the Community
  • Newsletter

Gastrointestinal Stromal Tumors

  • Qinlock (Ripretinib) for Advanced Gastrointestinal Stromal Tumors: What Patients Should Know
    December 31, 2025

    Qinlock (Ripretinib) for Advanced Gastrointestinal Stromal Tumors: What Patients Should Know

    Charles H. Weaver, MD
  • GIST – Gastrointestinal Stromal Tumors: Overview
    December 8, 2025

    GIST – Gastrointestinal Stromal Tumors: Overview

    Charles H. Weaver, MD
  • Pimitesib Treatment for GIST
    June 20, 2021

    Pimitesib Treatment for GIST

    Charles H. Weaver, MD
  • Sarcoma Centers Provide The Best Treatment and Access to Clinical Trials
    December 1, 2020

    Sarcoma Centers Provide The Best Treatment and Access to Clinical Trials

    Charles H. Weaver, MD
  • Gleevec (Imatinib) Treatment Improves Survival in GISTs
    June 9, 2020

    Gleevec (Imatinib) Treatment Improves Survival in GISTs

    Charles H. Weaver, MD
  • Ayvakit Precision Cancer Medicine Rare GIST PDGFRA  Mutation
    January 12, 2020

    Ayvakit Precision Cancer Medicine Rare GIST PDGFRA Mutation

    Charles H. Weaver, MD
  • Gastrointestinal Stromal Tumors Newsletter
    January 19, 2019

    Gastrointestinal Stromal Tumors Newsletter

    Charles H. Weaver, MD
  • SWOG Study Shows Strong Long-Term Survival Rates for Patients with GIST
    August 15, 2018

    SWOG Study Shows Strong Long-Term Survival Rates for Patients with GIST

    Charles H. Weaver, MD
  • Lutathera – Improves Outcomes for Neuroendocrine Tumors
    August 1, 2018

    Lutathera – Improves Outcomes for Neuroendocrine Tumors

    Charles H. Weaver, MD
  • Stivarga Approved for Treatment of Advanced Gastrointestinal Stromal Tumors
    July 11, 2018

    Stivarga Approved for Treatment of Advanced Gastrointestinal Stromal Tumors

    Charles H. Weaver, MD
  • Surgery in Responding Patients Feasible for GIST
    June 6, 2018

    Surgery in Responding Patients Feasible for GIST

    Charles H. Weaver, MD
  • Surgery for Residual GIST May Improve Outcomes
    June 2, 2018

    Surgery for Residual GIST May Improve Outcomes

    Charles H. Weaver, MD
1 2
Next Page
  • Sitemap
  • About Us
  • Advertising
  • Privacy Policy
 

Loading Comments...